Anticoagulation in patients with mechanical heart valves: follow the guidelines!

por Verheugt, Freek W.A.
Publicado 2015

Anticoagulants for secondary prevention after acute myocardial infarction: lessons from the past decade

por Atar, Dan, Bode, Christoph, Stuerzenbecher, André, Verheugt, Freek W A
Publicado 2014

Cerebral blood flow changes during tilt table testing in healthy volunteers, as assessed by Doppler imaging of the carotid and vertebral arteries

por van Campen, C. (Linda).M.C., Verheugt, Freek W.A., Visser, Frans C.
Publicado 2018

Physical activity measures in patients with myalgic encephalomyelitis/chronic fatigue syndrome: correlations between peak oxygen consumption, the physical functioning scale of the...

por van Campen, C. M. C., Rowe, Peter C., Verheugt, Freek W. A., Visser, Frans C.
Publicado 2020

Orthostatic chronotropic incompetence in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

por van Campen, C. (Linda) M.C., Verheugt, Freek W.A., Rowe, Peter C., Visser, Frans C.
Publicado 2023

Influence of end‐tidal CO(2) on cerebral blood flow during orthostatic stress in controls and adults with myalgic encephalomyelitis/chronic fatigue syndrome

por van Campen, C. (Linda) M. C., Rowe, Peter C., Verheugt, Freek W. A., Visser, Frans C.
Publicado 2023

Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: A quantitative, controlled study using Doppler echography

por van Campen, C. (Linda) M.C., Verheugt, Freek W.A., Rowe, Peter C., Visser, Frans C.
Publicado 2020

Cognitive Function Declines Following Orthostatic Stress in Adults With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

por van Campen, C. (Linda) M. C., Rowe, Peter C., Verheugt, Freek W. A., Visser, Frans C.
Publicado 2020

Numeric Rating Scales Show Prolonged Post-exertional Symptoms After Orthostatic Testing of Adults With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

por van Campen, C (Linda) M. C., Rowe, Peter C., Verheugt, Freek W. A., Visser, Frans C.
Publicado 2021

Short dual antiplatelet therapy and dual antiplatelet therapy de-escalation after primary percutaneous intervention: For whom and how

por Muthspiel, Marie, Kaufmann, Christoph C., Burger, Achim Leo, Panzer, Benjamin, Verheugt, Freek W. A., Huber, Kurt
Publicado 2022

Sympathoinhibitory effect of statins in chronic heart failure

por Gomes, Marc E., Lenders, Jacques W. M., Bellersen, Louise, Verheugt, Freek W. A., Smits, Paul, Tack, Cees J.
Publicado 2009

Cost-effectiveness Analysis of Rivaroxaban in the Secondary Prevention of Acute Coronary Syndromes in Sweden

por Begum, Najida, Stephens, Stephanie, Schoeman, Olaf, Fraschke, Anina, Kirsch, Bodo, Briere, Jean-Baptiste, Verheugt, Freek W. A., van Hout, Ben A.
Publicado 2015

A Structured Literature Review and International Consensus Validation of FORTA Labels of Oral Anticoagulants for Long-Term Treatment of Atrial Fibrillation in Older Patients (OAC-F...

por Pazan, Farhad, Collins, Ronan, Gil, Victor M., Hanon, Olivier, Hardt, Roland, Hoffmeister, Martin, Monteiro, Pedro, Quinn, Terence J., Ropers, Dieter, Sergi, Giuseppe, Verheugt, Freek W. A., Wehling, Martin
Publicado 2020

Correction to: A Structured Literature Review and International Consensus Validation of FORTA Labels of Oral Anticoagulants for Long-Term Treatment of Atrial Fibrillation in Older...

por Pazan, Farhad, Collins, Ronan, Gil, Victor M., Hanon, Olivier, Hardt, Roland, Hoffmeister, Martin, Monteiro, Pedro, Quinn, Terence J., Ropers, Dieter, Sergi, Giuseppe, Verheugt, Freek W. A., Wehling, Martin
Publicado 2021

Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE Trial

por Hu, Peter T., Lopes, Renato D., Stevens, Susanna R., Wallentin, Lars, Thomas, Laine, Alexander, John H., Hanna, Michael, Lewis, Basil S., Verheugt, Freek W. A., Granger, Christopher B., Jones, W. Schuyler
Publicado 2017

High T2-weighted signal intensity for risk prediction of sudden cardiac death in hypertrophic cardiomyopathy

por Gommans, D. H. Frank, Cramer, G. Etienne, Bakker, Jeannette, Dieker, Hendrik-Jan, Michels, Michelle, Fouraux, Michael A., Marcelis, Carlo L. M., Verheugt, Freek W. A., Timmermans, Janneke, Brouwer, Marc A., Kofflard, Marcel J. M.
Publicado 2017

Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial

por Jaspers Focks, Jeroen, Brouwer, Marc A, Wojdyla, Daniel M, Thomas, Laine, Lopes, Renato D, Washam, Jeffrey B, Lanas, Fernando, Xavier, Denis, Husted, Steen, Wallentin, Lars, Alexander, John H, Granger, Christopher B, Verheugt, Freek W A
Publicado 2016

Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: results from GARFIELD-AF

por Camm, Alan John, Steffel, Jan, Virdone, Saverio, Bassand, Jean-Pierre, Fox, Keith A A, Goldhaber, Samuel Z, Goto, Shinya, Haas, Sylvia, Turpie, Alexander G G, Verheugt, Freek W A, Misselwitz, Frank, Herreros, Ramón Corbalán, Kayani, Gloria, Pieper, Karen S, Kakkar, Ajay K
Publicado 2023

Early clinical outcomes as a function of use of newer oral P2Y(12) inhibitors versus clopidogrel in the EUROMAX trial

por Huber, Kurt, Ducrocq, Gregory, Hamm, Christian W, van ’t Hof, Arnoud, Lapostolle, Frédéric, Coste, Pierre, Gordini, Giovanni, Steinmetz, Jacob, Verheugt, Freek W A, Adgey, Jennifer, Nibbe, Lutz, Kaniĉ, Vojko, Clemmensen, Peter, Zeymer, Uwe, Bernstein, Debra, Prats, Jayne, Deliargyris, Efthymios N, Gabriel Steg, Ph
Publicado 2017

Multi‐Site Coronary Vein Sampling Study on Cardiac Troponin T Degradation in Non–ST‐Segment–Elevation Myocardial Infarction: Toward a More Specific Cardiac Troponin T Assay

por Damen, Sander A. J., Vroemen, Wim H. M., Brouwer, Marc A., Mezger, Stephanie T. P., Suryapranata, Harry, van Royen, Niels, Bekers, Otto, Meex, Steven J. R., Wodzig, Will K. W. H., Verheugt, Freek W. A., de Boer, Douwe, Cramer, G. Etienne, Mingels, Alma M. A.
Publicado 2019